I now have comprehensive material to write a thorough 35-mark answer. Let me compile it.
EPIDEMIOLOGY: Definition and Epidemiology of Tuberculosis (35 Marks)
PART I: DEFINITION OF EPIDEMIOLOGY
Etymology
The word "epidemiology" is derived from Greek roots:
- epi = among
- demos = people
- logos = study
It literally means "the study of what is among the people."
Historical Definitions
There are almost as many definitions of epidemiology as there are authors who have written on the subject. A short historical list includes:
- Parkin (1873): "That branch of medical science which treats epidemics."
- Frost (1927): "The science of the mass phenomena of infectious diseases."
- Greenwood (1934): "The study of disease, any disease, as a mass phenomenon."
- MacMahon (1960): "The study of the distribution and determinants of disease frequency in man."
Modern / Accepted Definition (IEA/Last)
The most widely accepted modern definition (John Last, Dictionary of Epidemiology, 4th ed., 2001), adopted by the International Epidemiological Association (IEA), states:
"The study of the occurrence and distribution of health-related events, states, and processes in specified populations, including the study of the determinants influencing such processes, and the application of this knowledge to control relevant health problems."
(Park's Textbook of Preventive and Social Medicine)
Breaking this definition down:
- Study - includes surveillance, observation, screening, hypothesis testing, analytic research, experiments, and prediction.
- Distribution - refers to analysis by time, place, and population (descriptive epidemiology).
- Determinants - the geophysical, biological, behavioural, social, cultural, economic, and political factors that influence health (analytical epidemiology).
- Health-related events, states, and processes - includes outbreaks, diseases, disorders, causes of death, behaviours, environmental and socio-economic processes, effects of preventive programmes, and use of health and social services.
- Specified populations - those with common contexts and identifiable characteristics.
- Application to control - makes explicit the ultimate aim: to promote, protect, and restore health.
Three Core Components
Although there is no single definition to which all epidemiologists subscribe, three components are common to most:
- Disease frequency - Measurement of how often disease occurs (rates, ratios such as incidence rate, prevalence rate, death rate).
- Distribution of disease - Studying patterns by time, place, and person (who, when, where).
- Determinants of disease - Identifying the underlying causes or risk factors (analytical epidemiology).
Aims of Epidemiology (IEA)
According to the IEA, epidemiology has three main aims:
- (a) To describe the distribution and magnitude of health and disease problems in human populations.
- (b) To identify aetiological factors (risk factors) in the pathogenesis of disease.
- (c) To provide data essential for planning, implementation, and evaluation of services for prevention, control, and treatment of disease.
The ultimate aim is to eliminate or reduce the health problem or its consequences, and to promote the health and well-being of society as a whole.
Epidemiology vs. Clinical Medicine
| Feature | Clinical Medicine | Epidemiology |
|---|
| Unit of study | Individual case | Defined population |
| Focus | Sick individual | Both sick and healthy |
| Method | Biomedical examination | Population-based studies |
| Output | Diagnosis, prognosis, treatment | Rates, risk factors, health programmes |
PART II: EPIDEMIOLOGY OF TUBERCULOSIS
Definition
Tuberculosis (TB) is a specific infectious disease caused by Mycobacterium tuberculosis. It primarily affects the lungs (pulmonary TB) but can also affect the intestines, meninges, bones and joints, lymph glands, skin, and other tissues. It is usually a chronic disease.
1. PROBLEM STATEMENT (Global Burden)
TB remains a worldwide public health problem despite the fact that the causative organism was discovered more than 100 years ago and effective drugs and vaccines are available, making TB a preventable and curable disease.
Global statistics:
- Approximately one-third of the world population is infected asymptomatically with M. tuberculosis, of whom 5-10% will develop clinical disease during their lifetime.
- The annual risk of TB infection in high-burden countries is estimated at 0.5-2%.
- Globally, 10 million people had TB in 2019.
- There were 1.2 million TB deaths among HIV-negative people plus an additional 208,000 deaths among HIV-positive people in 2019.
- One untreated patient with infectious pulmonary TB can infect 10-15 persons per year.
- In 2018, 86% of all TB cases were in the WHO regions of Southeast Asia (44%), Africa (24%), and the Western Pacific (18%).
- Most high-income countries have an incidence of less than 10 per 100,000 population.
- WHO has declared TB a global public health emergency and the WHO End TB Strategy (2014) aims to reduce TB deaths by 90% and new cases by 80% between 2015 and 2030.
(Murray & Nadel's Textbook of Respiratory Medicine; Park's Textbook of Preventive and Social Medicine)
2. BURDEN IN INDIA
- India accounts for 26% of the estimated global incident TB cases in 2019 - the highest TB burden country in the world in absolute numbers.
- Age distribution shows a predominance in adolescent and young adult age groups (15-30 years), indicating ongoing active disease transmission.
- Men (56%) account for the majority of cases; women 32%; children (<15 years) 12%.
3. NATURAL HISTORY OF TUBERCULOSIS
A. AGENT FACTORS
(a) The Agent:
- Mycobacterium tuberculosis - a facultative intracellular parasite, readily ingested by phagocytes and resistant to intracellular killing.
- Two strains important to man: human strain (responsible for the vast majority of cases) and bovine strain (mainly affects cattle; transmitted via infected milk).
- Atypical mycobacteria (e.g., M. kansasii, M. scrofulaceum, M. intercellulare) can also cause TB-like disease.
(b) Source of Infection:
- Human source (most common): An open case with sputum-positive TB. One infectious case can infect 10-15 people per year. Slow-multiplying bacilli can remain dormant for years and cause relapse.
- Bovine source: Infected milk. Less important in countries where milk is boiled before consumption.
(c) Communicability:
- Patients are infective as long as they remain untreated. Effective antimicrobial treatment reduces infectivity by 90% within 48 hours.
B. HOST FACTORS
(a) Age:
- TB affects all ages. In developing countries, infection rates rise sharply from childhood to adolescence. In India, infection rate rises from ~2% in the 0-14 year group to ~20% in the 15-24 year group. In developed countries, the disease is now more common in the elderly.
(b) Sex:
- More prevalent in males than in females.
(c) Heredity:
- TB is not a hereditary disease. However, twin studies indicate that inherited susceptibility is an important risk factor.
(d) Nutrition:
- Malnutrition is widely believed to predispose to tuberculosis. It affects disease development, treatment outcome, and disease spread - and remains a major factor in developing countries.
(e) Immunity:
- Man has no inherited immunity against TB. Immunity is acquired through natural infection or BCG vaccination. Cell-mediated immunity (delayed hypersensitivity) is the key immune mechanism; in most cases it limits further multiplication of bacilli.
(f) Comorbidities:
- HIV/AIDS: People living with HIV are 20-30 times more likely to develop TB than those without HIV. TB causes one in three HIV deaths, with 70% of HIV-TB cases in Africa. In 2018, 8.6% of all TB cases were among persons with HIV infection.
- Diabetes mellitus: Triples the risk of TB and increases likelihood of poor treatment outcomes. Worldwide prevalence of diabetes among TB patients is approximately 15.3%.
- Poverty: Crowded and poorly ventilated living spaces, malnutrition, and lack of empowerment to act on health issues all increase TB risk and transmission.
C. ENVIRONMENTAL / SOCIAL FACTORS
TB is frequently described as "a social disease with medical aspects" and "a barometer of social welfare."
Social and environmental determinants include:
- Overcrowding and poor housing - promote droplet transmission
- Poor ventilation - allows accumulation of droplet nuclei
- Malnutrition and undernutrition
- Poverty and low standard of living
- Smoking and alcohol abuse
- Lack of education and awareness
- Large families, early marriages, population explosion
Historically, TB began to decline in the Western world long before the advent of chemotherapy, primarily due to improvements in the standard of living and quality of life.
D. MODE OF TRANSMISSION
- TB is transmitted mainly by droplet infection and droplet nuclei generated by sputum-positive patients with pulmonary TB.
- Droplet particles must be fresh enough to carry a viable organism.
- Coughing generates the largest number of droplets of all sizes.
- The frequency and vigour of cough and the ventilation of the environment influence transmission.
- TB is not transmitted by fomites (dishes, articles used by patients); sterilization of these articles is therefore of little value.
- Patients with extrapulmonary TB or smear-negative TB constitute a minimal hazard for transmission.
E. INCUBATION PERIOD
- Time from infection to development of a positive tuberculin test: 3 to 6 weeks.
- Thereafter, development of disease depends on: closeness of contact, extent of disease, sputum positivity of the source case (dose of infection), and host-parasite relationship.
- The incubation period may therefore range from weeks, months to years.
4. EPIDEMIOLOGICAL INDICES
Key epidemiological indicators for measuring the TB burden:
| Index | Description |
|---|
| Prevalence of infection | % showing positive tuberculin test; represents cumulative experience |
| Annual Infection Rate (AIR) | % newly infected per year (tuberculin conversion index); in developing countries, 1% AIR = ~50 smear-positive cases per 100,000 population |
| Incidence rate | New cases per 100,000 population per year |
| Case Notification Rate | New and recurrent TB cases notified to WHO per 100,000 population |
| Case Detection Rate | Notifications of new and relapse cases / estimated incidence |
| Prevalence of drug-resistant cases | % of patients with drug-resistant M. tuberculosis |
5. DRUG-RESISTANT TUBERCULOSIS
A major threat to global TB control:
- MDR-TB: Resistant to at least isoniazid and rifampicin (the two most effective first-line drugs).
- XDR-TB: MDR-TB also resistant to at least one fluoroquinolone and at least one injectable second-line agent.
- In 2018, an estimated 500,000 people developed rifampicin-resistant TB; 78% had MDR-TB.
- Nearly half of all rifampicin-resistant/MDR-TB cases were from India (24%), China (13%), and Russia (10%).
- XDR-TB was first reported in 2006 and has since been reported in 131 WHO member states (as of 2018).
- Cure rates for MDR-TB (56%) are far lower than drug-susceptible TB (85%).
(Murray & Nadel's Textbook of Respiratory Medicine)
6. TUBERCULOSIS AND HIV (THE DUAL EPIDEMIC)
- TB causes one in three HIV deaths globally.
- Most HIV-TB cases and deaths are in Africa (where 70% of the 37 million PLHIV live).
- Co-infection creates a vicious cycle: HIV-mediated immunosuppression accelerates TB progression, and TB accelerates HIV disease.
7. GLOBAL STRATEGY AND TARGETS
| Strategy | Key Features |
|---|
| DOTS (core of Stop TB strategy) | Case detection + short-course chemotherapy under supervision |
| End TB Strategy (2014) | Reduce TB deaths by 90% and new cases by 80% (2015-2030) |
| SDG Target | End TB epidemic by 2030 |
| WHO 2035 Target | 95% reduction in deaths; 90% decline in TB incidence |
| UN High-Level Meeting (2018) | Treat 40 million people for TB (2018-2022); 30 million on TB preventive treatment |
8. IMPACT OF COVID-19 ON TB
The COVID-19 pandemic threatens to reverse recent progress in reducing global TB burden. It is estimated that the global number of TB deaths could increase by 0.2-0.4 million in 2020 alone if health services are disrupted.
Summary Table: Epidemiological Triad for Tuberculosis
| Factor | Key Points |
|---|
| Agent | M. tuberculosis; human and bovine strains; drug resistance (MDR, XDR) |
| Host | All ages; males > females; malnutrition; no natural immunity; HIV, DM increase risk |
| Environment | Overcrowding, poor ventilation, poverty, malnutrition, low education |
| Transmission | Droplet nuclei; not by fomites |
| Incubation | Positive tuberculin test in 3-6 weeks; disease may take weeks to years |
Sources:
- Park's Textbook of Preventive and Social Medicine (Park K.), Chapter on Epidemiology and Tuberculosis
- Murray & Nadel's Textbook of Respiratory Medicine, Chapter 51 (Epidemiology of Tuberculosis)